000710 Stock Overview
A genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Berry Genomics Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.19 |
| 52 Week High | CN¥16.48 |
| 52 Week Low | CN¥5.40 |
| Beta | 0.70 |
| 11 Month Change | 4.55% |
| 3 Month Change | 35.15% |
| 1 Year Change | -30.06% |
| 33 Year Change | -56.28% |
| 5 Year Change | -73.68% |
| Change since IPO | -83.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| 000710 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -2.9% | -2.6% | -2.1% |
| 1Y | -30.1% | -20.9% | 2.8% |
Return vs Industry: 000710 underperformed the CN Biotechs industry which returned -17.3% over the past year.
Return vs Market: 000710 underperformed the CN Market which returned 5.4% over the past year.
Price Volatility
| 000710 volatility | |
|---|---|
| 000710 Average Weekly Movement | 7.1% |
| Biotechs Industry Average Movement | 8.9% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 000710 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 000710's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 1,448 | Yang Gao | www.berrygenomics.com |
Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcriptional regulation, single cell/spatial sequencing, animal and plant genome resequencing, genome denovo sequencing, and microbial sequencing, as well as big data services.
Berry Genomics Co.,Ltd Fundamentals Summary
| 000710 fundamental statistics | |
|---|---|
| Market cap | CN¥3.25b |
| Earnings (TTM) | -CN¥281.85m |
| Revenue (TTM) | CN¥1.11b |
2.9x
P/S Ratio-11.5x
P/E RatioIs 000710 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000710 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.11b |
| Cost of Revenue | CN¥600.55m |
| Gross Profit | CN¥507.93m |
| Other Expenses | CN¥789.78m |
| Earnings | -CN¥281.85m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.80 |
| Gross Margin | 45.82% |
| Net Profit Margin | -25.43% |
| Debt/Equity Ratio | 5.6% |
How did 000710 perform over the long term?
See historical performance and comparison